Oncologix Tech Inc (OCLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 11-2002 | 08-2002 | 05-2002 | 02-2002 | 11-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 330 | 350 | 600 | 10 | 220 |
| Marketable Securities | 0 | 20 | 20 | 20 | 20 |
| Receivables | 60 | 70 | 60 | 50 | 40 |
| Other current assets | 100 | 70 | 40 | 50 | 60 |
| TOTAL | $490 | $510 | $720 | $130 | $340 |
| Non-Current Assets | |||||
| PPE Net | 3,980 | 3,960 | 3,970 | N/A | 3,970 |
| Other Non-Current Assets | 7,040 | 7,340 | 7,670 | 7,960 | 8,340 |
| TOTAL | $11,020 | $11,300 | $11,640 | $7,960 | $12,310 |
| Total Assets | $8,980 | $9,500 | $10,240 | $10,170 | $10,980 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 690 | 700 | 610 | 630 | 510 |
| Accrued Expenses | 0 | 140 | 0 | 0 | 0 |
| Other current liabilities | 160 | 0 | 10 | 10 | 10 |
| TOTAL | $1,030 | $1,040 | $890 | $650 | $520 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,030 | $1,040 | $890 | $650 | $520 |
| Shareholders' Equity | |||||
| Common Shares | 10 | 10 | 10 | 10 | 10 |
| Retained earnings | -24,940 | -23,480 | -20,760 | -19,470 | -18,420 |
| Other shareholders' equity | 0 | 880 | 0 | 0 | -10 |
| TOTAL | $7,950 | $8,450 | $9,350 | $9,520 | $10,450 |
| Total Liabilities And Equity | $8,980 | $9,490 | $10,240 | $10,170 | $10,970 |